Background: We set out in this study to demonstrate the adverse effect profile of methotrexate when used in the treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in a district ...

Of the latter two groups, there was no direct evidence that any of the deaths could be solely attributed to methotrexate use. There were no recorded deaths in the PsA group during the study period.

1 INSERM, U1059-SAINBIOSE, University of Lyon, Saint-Etienne, France 2 University Hospital of Saint-Etienne, Rheumatology, Saint-Etienne, France Background Methotrexate (MTX) is the recommended ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Background Methotrexate (MTX) is the most widely used anti-rheumatic drug in the treatment of Rheumatoid Arthritis (RA) due to low costs, efficacy and an acceptable safety profile. However MTX has ...

Assertio Holdings, Inc.’s ASRT share price has surged by 5.21%, which has investors questioning if this is right time to sell ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater likelihood of cancer relapse when they were treated with biologic agents, ...

and methotrexate as CDs; and azathioprine (and its active metabolite 6-mercaptopurine) and mycophenolate mofetil as “cytotoxic immunosuppressants”. This review concentrates on the use of ISDs and CDs ...

SynAct Pharma AB (publ) ("SynAct") announced today that the Unites States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application US 17/609,849 with claims covering ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced” in favor of other approaches, including artificial intelligence ...